118 related articles for article (PubMed ID: 27477203)
1. Quantitative analysis of B-lymphocyte migration directed by CXCL13.
Liu X; Asokan SB; Bear JE; Haugh JM
Integr Biol (Camb); 2016 Aug; 8(8):894-903. PubMed ID: 27477203
[TBL] [Abstract][Full Text] [Related]
2. Linking morphodynamics and directional persistence of T lymphocyte migration.
Liu X; Welf ES; Haugh JM
J R Soc Interface; 2015 May; 12(106):. PubMed ID: 25904526
[TBL] [Abstract][Full Text] [Related]
3. B cell zone reticular cell microenvironments shape CXCL13 gradient formation.
Cosgrove J; Novkovic M; Albrecht S; Pikor NB; Zhou Z; Onder L; Mörbe U; Cupovic J; Miller H; Alden K; Thuery A; O'Toole P; Pinter R; Jarrett S; Taylor E; Venetz D; Heller M; Uguccioni M; Legler DF; Lacey CJ; Coatesworth A; Polak WG; Cupedo T; Manoury B; Thelen M; Stein JV; Wolf M; Leake MC; Timmis J; Ludewig B; Coles MC
Nat Commun; 2020 Jul; 11(1):3677. PubMed ID: 32699279
[TBL] [Abstract][Full Text] [Related]
4. The Rap GTPases mediate CXCL13- and sphingosine1-phosphate-induced chemotaxis, adhesion, and Pyk2 tyrosine phosphorylation in B lymphocytes.
Durand CA; Westendorf J; Tse KW; Gold MR
Eur J Immunol; 2006 Aug; 36(8):2235-49. PubMed ID: 16821235
[TBL] [Abstract][Full Text] [Related]
5. Spin90 deficiency increases CXCL13-mediated B cell migration.
Park SH; Kim HR; Jun CD; Song WK; Park SG
Scand J Immunol; 2014 Sep; 80(3):191-7. PubMed ID: 24965518
[TBL] [Abstract][Full Text] [Related]
6. Migratory cues controlling B-lymphocyte trafficking in human lymph nodes.
Park SM; Brooks AE; Chen CJ; Sheppard HM; Loef EJ; McIntosh JD; Angel CE; Mansell CJ; Bartlett A; Cebon J; Birch NP; Dunbar PR
Immunol Cell Biol; 2021 Jan; 99(1):49-64. PubMed ID: 32740978
[TBL] [Abstract][Full Text] [Related]
7. EBI2 regulates CXCL13-mediated responses by heterodimerization with CXCR5.
Barroso R; Martínez Muñoz L; Barrondo S; Vega B; Holgado BL; Lucas P; Baíllo A; Sallés J; Rodríguez-Frade JM; Mellado M
FASEB J; 2012 Dec; 26(12):4841-54. PubMed ID: 22913878
[TBL] [Abstract][Full Text] [Related]
8. The direction of migration of T-lymphocytes under flow depends upon which adhesion receptors are engaged.
Dominguez GA; Anderson NR; Hammer DA
Integr Biol (Camb); 2015 Mar; 7(3):345-55. PubMed ID: 25674729
[TBL] [Abstract][Full Text] [Related]
9. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity.
Ansel KM; Harris RB; Cyster JG
Immunity; 2002 Jan; 16(1):67-76. PubMed ID: 11825566
[TBL] [Abstract][Full Text] [Related]
10. CXCL13 production in B cells via Toll-like receptor/lymphotoxin receptor signaling is involved in lymphoid neogenesis in chronic obstructive pulmonary disease.
Litsiou E; Semitekolou M; Galani IE; Morianos I; Tsoutsa A; Kara P; Rontogianni D; Bellenis I; Konstantinou M; Potaris K; Andreakos E; Sideras P; Zakynthinos S; Tsoumakidou M
Am J Respir Crit Care Med; 2013 Jun; 187(11):1194-202. PubMed ID: 23525932
[TBL] [Abstract][Full Text] [Related]
11. Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis.
Li Y; Wang W; Tang L; He X; Yan X; Zhang X; Zhu Y; Sun J; Shi Y; Ma X; Mackay IR; Gershwin ME; Han Y; Hou J
Hepatology; 2015 Jun; 61(6):1998-2007. PubMed ID: 25627620
[TBL] [Abstract][Full Text] [Related]
12. Integrin-mediated long-term B cell retention in the splenic marginal zone.
Lu TT; Cyster JG
Science; 2002 Jul; 297(5580):409-12. PubMed ID: 12130787
[TBL] [Abstract][Full Text] [Related]
13. Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis.
Weiss JM; Robinet M; Aricha R; Cufi P; Villeret B; Lantner F; Shachar I; Fuchs S; Souroujon MC; Berrih-Aknin S; Le Panse R
Oncotarget; 2016 Feb; 7(7):7550-62. PubMed ID: 26771137
[TBL] [Abstract][Full Text] [Related]
14. Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint.
Manzo A; Vitolo B; Humby F; Caporali R; Jarrossay D; Dell'accio F; Ciardelli L; Uguccioni M; Montecucco C; Pitzalis C
Arthritis Rheum; 2008 Nov; 58(11):3377-87. PubMed ID: 18975336
[TBL] [Abstract][Full Text] [Related]
15. Chapter 15. A microfluidics-based method for chemoattractant gradients.
Lin F
Methods Enzymol; 2009; 461():333-47. PubMed ID: 19480926
[TBL] [Abstract][Full Text] [Related]
16. Key role of CXCL13/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS.
Pranzatelli MR; Tate ED; McGee NR; Travelstead AL; Ransohoff RM; Ness JM; Colliver JA
J Neuroimmunol; 2012 Feb; 243(1-2):81-8. PubMed ID: 22264765
[TBL] [Abstract][Full Text] [Related]
17. High-Speed Single-Molecule Tracking of CXCL13 in the B-Follicle.
Miller H; Cosgrove J; Wollman AJM; Taylor E; Zhou Z; O'Toole PJ; Coles MC; Leake MC
Front Immunol; 2018; 9():1073. PubMed ID: 29872430
[TBL] [Abstract][Full Text] [Related]
18. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
[TBL] [Abstract][Full Text] [Related]
19. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
Krumbholz M; Theil D; Cepok S; Hemmer B; Kivisäkk P; Ransohoff RM; Hofbauer M; Farina C; Derfuss T; Hartle C; Newcombe J; Hohlfeld R; Meinl E
Brain; 2006 Jan; 129(Pt 1):200-11. PubMed ID: 16280350
[TBL] [Abstract][Full Text] [Related]
20. Aberrant B1 cell migration into the thymus results in activation of CD4 T cells through its potent antigen-presenting activity in the development of murine lupus.
Sato T; Ishikawa S; Akadegawa K; Ito T; Yurino H; Kitabatake M; Yoneyama H; Matsushima K
Eur J Immunol; 2004 Dec; 34(12):3346-58. PubMed ID: 15495164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
